Phase 2 ACL Clinical Trials
13 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–13 of 13 trials
Recruiting
Phase 2
Comparison of Functional Outcomes Following Arthroscopic ACL Reconstruction With Peroneus Longus Autograft With and Without Intra-articular Platelet-Rich Plasma Injection.
ACL reconstructionPRPIntraarticular Injection
Lahore General Hospital60 enrolled1 locationNCT07470359
Recruiting
Phase 2
Subdermal Implant-bioabsorbable Oxandrolone Pellet For Rehabilitation Following Anterior Cruciate Ligament (ACL) Surgical Reconstruction
Anterior cruciate ligament (ACL) reconstruction
Science Valley Research Institute96 enrolled6 locationsNCT06974526
Recruiting
Phase 2Phase 3
Early Double Sequential Defibrillation in Out of Hospital Cardiac Arrest
sudden deathVentricular FibrillationOut-of-hospital cardiac arrest+3 more
Gabriel Riva916 enrolled14 locationsNCT07174986
Recruiting
Phase 1Phase 2
A Phase I/II Study of Intraperitoneal Paclitaxel in Patients With Metastatic Appendiceal Adenocarcinoma
Metastatic Appendiceal AdenocarcinomaIntraperitoneal Paclitaxel
M.D. Anderson Cancer Center39 enrolled1 locationNCT06207305
Recruiting
Phase 2
Nephron-sparing Treatment of Tislelizumab + Nab-Paclitaxel for Renal Pelvic Cancer
TislelizumabPD-1 InhibitorKidney-sparing+2 more
Tianjin Medical University Second Hospital35 enrolled1 locationNCT07233252
Recruiting
Phase 2
Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Capecitabine in the Treatment of Advanced Triple-negative Breast Cancer
Triple-Negative Breast CancerNab-paclitaxel
Hebei Medical University Fourth Hospital414 enrolled1 locationNCT04159142
Recruiting
Phase 2
Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Epirubicin in the Neoadjuvant Therapy for Breast Cancer
Breast CancerTriple-Negative Breast CancerNab-paclitaxel
Hebei Medical University Fourth Hospital520 enrolled1 locationNCT04138719
Recruiting
Phase 2
Neoadjuvant Tislelizumab in Combination With Nab-Paclitaxel for UTUC
Neoadjuvant TherapyPD-1 InhibitorUpper Tract Urothelial Carcinoma+1 more
Tianjin Medical University Second Hospital35 enrolled1 locationNCT07126119
Recruiting
Phase 2
Neoadjuvant Tislelizumab + Nab-Paclitaxel Followed by Distal Ureterectomy for Ureteral Cancer
Neoadjuvant TherapyTislelizumabPD-1 Inhibitor+3 more
Tianjin Medical University Second Hospital35 enrolled1 locationNCT07125547
Recruiting
Phase 2
Preventing Injured Knees From osteoArthritis: Severity Outcomes
Osteoarthritis, KneePost-traumatic OsteoarthritisACL Tear
Brigham and Women's Hospital512 enrolled9 locationsNCT06096259
Recruiting
Phase 2
A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome (COMBAT Trial).
Liver CirrhosisDecompensated Cirrhosis of LiverAcute on Chronic Liver Failure (ACLF)
European Foundation for Study of Chronic Liver Failure90 enrolled9 locationsNCT05895136
Completed
Phase 2
A Safety Study of Oraxol (HM30181 + oral paclitaxel) in Cancer Patients
Cancer requiring treatment with IV paclitaxel
Kinex Pharmaceuticals Inc44 enrolled7 locationsACTRN12615000881538
Completed
Phase 2
Clinical Study of New Intraocular Lens Design in Participants requiring Bilaterial Cataract Removal
Cataract extraction and artificial lens implantation for vision acuity restoration for far, intermediate and near vision with reduced need for further spectacle correction/dependence.
Abbott Medical Optics Inc50 enrolled1 locationACTRN12613000262707